Poietis Biosystems

Laser-Assisted Bioprinting, the patented technology behind the NGB platform. Nozzle-free, single-cell precision, up to 95% cell viability, validated on 40+ cell types.

The Poietis Biosystems brochure describes the NGB platform, its modules, and the science behind laser-assisted bioprinting.

The NGB-C: the first clinical-grade, GMP-compliant laser bioprinter. Built on the NGB-R architecture for a seamless continuum from research to ATMP manufacturing.

The NGB-R laser-assisted bioprinter for research: a modular platform - laser printhead, in-line microscope, 6-axis arm, PickCell. 2 µm resolution, nozzle-free.

Articles on Poietis Biosystems collaborations, milestones and perspectives on laser-assisted bioprinting.

Poietis founder Fabien Guillemot participates in the European Commission JRC workshop on 3D bioprinting standards in Brussels, October 2025.

In-depth publications and research on laser-assisted bioprinting - the science behind the NGB platform. Filter by tissue and topic.

Poietis Biosystems provides articles, events, press releases, and scientific publications on laser-assisted bioprinting, organized by research area.

Poietis Biosystems will showcase the NGB-R at TERMIS-EU 2026 in Palma de Mallorca, offering live demonstrations of laser-assisted bioprinting.

The page lists articles on collaborations and research, along with events where Poietis Biosystems presents its work and discusses projects.

Meet NGB Biosystems (formerly Poietis) at Biofabrication 2026, ISBF conference in Monterrey, Mexico, 2-6 November 2026: laser-assisted bioprinting, NGB-R and NGB-C.

Poietis Biosystems exhibited at the EUROoCS 2026 Annual Meeting in Braga, Portugal, 22-24 June 2026, meeting the organ-on-chip community to present laser-assisted bioprinting of 3D tissue models with the NGB platform.

Poietis Biosystems builds the NGB laser-assisted bioprinting platform, from research (NGB-R) to GMP manufacturing (NGB-C). Pioneering bioprinting since 2014, near Bordeaux.

Poietis Biosystems offers demonstrations of the NGB platform, consultations with scientists, and visits to its facilities in Pessac, Bordeaux, for research and clinical applications.

Laser-assisted bioprinting from the bench to the clinic. NGB-R for research, NGB-C for GMP manufacturing. Single-cell precision, built on 20+ years of peer-reviewed research.

Legal notice for the Poietis Biosystems website: publisher, hosting, credits, and liability.

TERMIS-EU 2026 in Palma de Mallorca (21–24 April 2026) will feature a live demonstration of the NGB bioprinter by Poietis Biosystems at Stand 8.